SCHEMBL26423480

SCHEMBL26423480

c1cnc2c(c1)oc1nc3ccncc3nc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 1/20 0.39
ALDH1A1 P00352 3/20 0.35
HSD17B10 Q99714 3/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
KDM4E B2RXH2 4/20 0.33
HTT P42858 2/20 0.32
TP53 P04637 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
LMNA P02545 2/20 0.32
HSP90AA1 P07900 2/20 0.32
GMNN O75496 1/20 0.32
MMP2 P08253 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
MAPT P10636 1/20 0.32
MMP9 P14780 1/20 0.32
ALOX15 P16050 1/20 0.32
TSHR P16473 1/20 0.32
NFKB1 P19838 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26423468 1.00 MAPK14 (0.39) MAPK14ALDH1A1HSD17B10MEN1KMT2A
SCHEMBL26423373 0.85 ALDH1A1 (0.42) MAPK14ALDH1A1HSD17B10MEN1KMT2A
SCHEMBL26423453 0.79 KDM4E (0.36) ALDH1A1KDM4ELMNAHSP90AA1CYP3A4
SCHEMBL26423451 0.79 KDM4E (0.36) ALDH1A1KDM4ELMNAHSP90AA1CYP3A4
SCHEMBL26423473 0.78 DAGLA (0.32) ALDH1A1KDM4EHTT
SCHEMBL26423471 0.78 DAGLA (0.32) ALDH1A1KDM4EHTT
SCHEMBL26423479 0.76 KDM4E (0.39) MAPK14ALDH1A1HSD17B10KDM4EHTT
SCHEMBL26423461 0.76 IDO1 (0.34) ALDH1A1KDM4EHTT
SCHEMBL26423469 0.76 KDM4E (0.39) MAPK14ALDH1A1HSD17B10KDM4EHTT
SCHEMBL26423460 0.76 IDO1 (0.34) ALDH1A1KDM4EHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230127291-A1 HETEROCYCLIC ARYLAMINE COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY PANEL WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230127291-A1 HETEROCYCLIC ARYLAMINE COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY PANEL OCIAD2, OCIAD1, AZI2 MAPK14 1074/4885ALDH1A1 302/4885HSD17B10 2546/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.